England’s former deputy chief medical officer has accepted a position with biotechnology firm Moderna. Sir Jonathan Van-Tam, 59, one of the many faces of the Government’s Covid response, has become a part-time consultant for the vaccine giant that helped pioneer the live-saving
Moderna Inc. announced on Tuesday that a late-stage trial found that its experimental messenger RNA vaccine for respiratory syncytial virus was 83.7% effective in preventing at least two symptoms in adults ages 60 and older. RSV produces symptoms similar to a cold